Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Datamonitor
|
$175.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: GlobalData
|
$250.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
H Lundbeck A/S' Shares Fall 16.2% After Lowering Outlook-Reuters
Reuters reported that H Lundbeck A/S' shares were 16.2% down in rate 81.00 after the Company announced on December 19, 2012 its lowered outlook for fiscal year 2013 and fiscal year 2014.
Latest Developments for H Lundbeck A/S
- H Lundbeck A/S Lowers FY 2013 EBIT Guidance Following European Commission's Fine of EUR 93 Million-DJ
- H Lundbeck A/S Announces Positive Results from Pre-Clinical Studies with Vortioxetine
- H Lundbeck A/S and Takeda Pharmaceutical Company Limited's Vortioxetine Clinical Phase III Data Show Improvement in Symptoms of Major Depression
- H Lundbeck A/S Reaffirms FY 2013 Guidance
- Share this
- Link this
- Digg this
Follow Reuters